Skip to the answer

Pyridostigmine Uses, Dosage, Side Effects and Interactions

Brand names
Mestinon

Mestinon is a pyridostigmine brand from before 1982 that comes as a tablet, an oral solution and an extended-release tablet. An FDA-approved generic with the same active ingredient is listed.

Mestinon Timespan

Mestinon Timespan is a brand name for pyridostigmine. It is not in the FDA’s directory today; generic pyridostigmine is.

Regonol

Regonol is a pyridostigmine brand from before 1982 that comes as an injection. No generic is listed as injections, though generic pyridostigmine is listed as extended-release tablets, oral solution and tablets.

Pyridostigmine is a cholinesterase inhibitor used to treat myasthenia gravis (oral solution, tablets and extended-release tablets), to reverse muscle relaxants after surgery (Regonol injection), and, in military-only products, as pretreatment against soman nerve agent poisoning.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About PyridostigmineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Pyridostigmine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Pyridostigmine (Mestinon) is the usual first medicine for myasthenia gravis weakness, blocking the enzyme that breaks down acetylcholine so nerve signals reach muscles more freely; it has been around since about 1955 with FDA-approved generics, and its Regonol injection reverses muscle relaxants after surgery. Most people tolerate it well, though stomach cramps, loose stools, extra saliva and muscle twitching are common. Watch for weakness that gets worse instead of better, which can mean too much medicine (cholinergic crisis) and needs prompt medical care. The boxed warning applies only to a separate military-only product, which protects against soman nerve agent only alongside protective gear and quick atropine and pralidoxime.

Key Takeaways From the HelloPharmacist Team

  • Time doses so strength peaks when you need it most; extended-release tablets go once or twice daily, at least 6 hours apart.
  • Get emergency help for trouble breathing, fainting or severe dizziness, and report a slow or irregular heartbeat or chest tightness.
  • Tell your surgeon and anesthesia team you take it, because it changes how muscle relaxants used during surgery work.
  • FDA-approved generics are listed, so ask your pharmacist which version your insurance plan covers.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Pyridostigmine.

This warning applies to the military-only pyridostigmine product used before soman nerve agent exposure.

Pyridostigmine alone will not protect you from soman. It only works as pretreatment, taken well before exposure, and only when atropine and pralidoxime are given quickly after exposure. Do not take it after exposure, and stop it at the first sign of poisoning. Taken right before or during exposure, it may make things worse.

Protective gear such as masks, hoods and overgarments is the main protection. Do not rely on this drug alone.

Read the full warning on DailyMed →

Pyridostigmine by the Numbers

Strengths
6
across 4 forms
Makers and packagers
20
Earliest FDA record
1955
Rank by Medicaid prescriptions
#645 of 1,682 drugs
More prescriptions than 61% of the 1,682 drugs we measure
50,282 prescriptions, Q1–Q4 2025

Patient Information Guide for Pyridostigmine

What It’s Used For

Pyridostigmine has different approved uses depending on the product.

  • Mestinon and pyridostigmine bromide oral solution, tablets and extended-release tablets: treat myasthenia gravis.
  • Regonol (injection): reverses the muscle-relaxing effects of nondepolarizing muscle relaxants.
  • Military-only pyridostigmine bromide tablets and extended-release tablets: pretreatment against the lethal effects of soman nerve agent poisoning in adults (evidence from animal studies).

How It Works

Pyridostigmine is a reversible cholinesterase inhibitor. It stops the enzyme cholinesterase from breaking down acetylcholine, a chemical messenger between nerves and muscles.

This lets nerve signals reach muscles more freely. For nerve agent pretreatment, it temporarily occupies enzyme sites so soman cannot lock them permanently.

Drug Class

Drug Class

  • Cholinesterase Inhibitor
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Cholinesterase Inhibitor

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Cholinesterase Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Pyridostigmine in the FDA’s index.

From our Patient Information GuidePyridostigmine is a reversible cholinesterase inhibitor. It stops the enzyme cholinesterase from breaking down acetylcholine, a chemical messenger between nerves and muscles. This lets nerve signals reach muscles more freely. Read How Pyridostigmine Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Pyridostigmine in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Anticholinesterases

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Dosing depends on the product, so follow your prescriber and label.

  • Oral solution and conventional tablets: dose size and timing are adjusted to the individual, spaced for best relief when strength is needed most.
  • Mestinon Timespan tablets: slow release, so fewer doses a day may be needed.
  • Regonol: given by vein by experienced clinicians, usually with atropine or glycopyrrolate.
  • Military-only extended-release tablet: taken once daily with a medium-fat or high-fat meal.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Pyridostigmine Bromide 60 Mg Tablets

Myasthenia gravis
Adults and patients with average needs Usual dose Ten tablets (60 mg each) a day
  • The average dose is ten 60 mg tablets, spaced to provide maximum relief when maximum strength is needed

Good to know

Size and frequency of the dosage must be adjusted to the needs of the individual patient

People with severe cases Highest dose 25 tablets (60 mg each) a day
  • As many as 25 tablets a day may be required

Good to know

Adjusted to the needs of the individual patient

People with mild cases Two to twelve tablets a day may suffice

Good to know

Adjusted to the needs of the individual patient

See the Full Dosing Instructions on DailyMed →

Pryidostigmine Bromide

Myasthenia gravis
People with severe cases As many as 25 teaspoonfuls a day may be required

Also 25 teaspoonfuls a day

People with mild cases One to six teaspoonfuls a day may suffice
People with average needs, including children Usual dose Ten teaspoonfuls (5 mL each, 60 mg per 5 mL) a day
  • The average dose is ten 5 mL teaspoonfuls daily, spaced to provide maximum relief when maximum strength is needed

Good to know

Size and frequency of the dosage must be adjusted to the needs of the individual patient; solution permits fractions of 60 mg doses for children and brittle myasthenic patients

See the Full Dosing Instructions on DailyMed →

Pyridostigmine Extended-Release Tablets

Myasthenia gravis
For adults
Usual dose One to three extended-release tablets (180 mg each) once or twice a day
  • One to three Extended-release Tablets, 180 mg, once or twice daily, will usually be sufficient to control symptoms
  • Interval between doses should be at least 6 hours

Good to know

Needs of certain individuals may vary markedly from this average; the more rapidly acting tablets or syrup may be used in conjunction

See the Full Dosing Instructions on DailyMed →

Pyridostigmine Bromide 30 Mg Tablets

Myasthenia gravis
People with average needs Usual dose Twenty tablets (30 mg each) a day
  • The average dose is twenty 30 mg tablets, spaced to provide maximum relief when maximum strength is needed

Good to know

Size and frequency of the dosage must be adjusted to the needs of the individual patient

People with severe cases Highest dose 50 tablets (30 mg each) a day
  • As many as 50 tablets a day may be required
People with mild cases Two to twelve tablets a day may suffice

See the Full Dosing Instructions on DailyMed →

Pyridostigmine Injection

Reversing the effects of muscle relaxants used in surgery
Adults Usual dose 0.6 to 1.2 mg

Step by step

  1. Reversal doses range from 0.1 to 0.25 mg/kg
  2. Atropine sulfate (0.6 to 1.2 mg) or an equipotent dose of glycopyrrolate given immediately prior to or simultaneously

Good to know

Dosage must be individualized; for intravenous use only

Children Safety and efficacy have not been established, therefore no dosing recommendations can be made

See the Full Dosing Instructions on DailyMed →

Side Effects

Most side effects come from extra acetylcholine activity.

Common side effects

  • Diarrhea
  • Stomach pain or cramps
  • Nausea and vomiting
  • Muscle twitching or cramps
  • Painful periods (dysmenorrhea)
  • Increased saliva or sweating
  • Headache

When to get medical help

  • Get emergency help for trouble breathing, severe dizziness or loss of consciousness.
  • Seek care for increasing muscle weakness, which can signal too much medicine (cholinergic crisis).
  • Call your doctor if you get a skin rash, especially if you are sensitive to bromide.
  • Report a slow heart rate, irregular heartbeat or chest tightness.
  • Seek help for confusion, agitation or hallucinations after too much medicine.

Seek help right away for trouble breathing, severe dizziness or fainting.

Warnings and Precautions

  • Military-only product: it will not protect against soman alone. It must be used with protective garments plus atropine and pralidoxime, and never after exposure.
  • Use with caution in asthma, COPD, slow heart rate, irregular heartbeat and with beta blockers.
  • Bromide-sensitive people may get a skin rash.
  • Regonol contains benzyl alcohol, which carries risk for newborns, and requires close breathing monitoring.

Interactions

Several drugs can add to or change pyridostigmine's effects.

  • Mefloquine: added stomach and heart rate effects.
  • Glaucoma drugs of the same type: may worsen night vision.
  • Narcotics: may worsen slow heart rate.
  • Muscle relaxants used in surgery: effects may be stronger or weaker.
  • Aminoglycosides, some anesthetics and heart rhythm drugs: use cautiously.
  • Dexpanthenol: additive effect.

Interactions Listed in the FDA-Approved Label

From the Pyridostigmine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • What happensMay have additive effects on the gastrointestinal tract, most commonly loose bowels, and on the atrial rate.
  • Anticholinesterase drugs for glaucoma
    What happensMay have an additive effect that may cause or exacerbate problems with night vision.
  • Narcotics
    What happensThe bradycardia associated with narcotics may exacerbate pyridostigmine-induced bradycardia.
  • Depolarizing neuromuscular blocking agents For example: succinylcholine
    What happensThe degree of neuromuscular blockade may be enhanced by previously administered pyridostigmine bromide.
    What to doParticular caution should be observed during surgery.
  • Nondepolarizing neuromuscular blocking agents For example: pancuronium bromide
    What happensDoses may need to be increased in patients previously given pyridostigmine bromide.
  • Atropine
    What happensAtropine antagonizes the muscarinic effects of pyridostigmine bromide.
    What to doThis interaction is used to counteract the muscarinic symptoms of pyridostigmine bromide toxicity.
  • Aminoglycoside antibiotics, local and some general anesthetics, antiarrhythmic agents, and other drugs that interfere with neuromuscular transmission
    What happensThese drugs interfere with neuromuscular transmission; anticholinesterase agents are sometimes effective in reversing block induced by aminoglycosides.
    What to doShould be used cautiously, if at all, during treatment with pyridostigmine bromide.
  • Drugs converted to pantothenic acid For example: dexpanthenol
    What happensMay have additive effects by increasing production of acetylcholine.
Read the label’s full interactions text

7 DRUG INTERACTIONS Mefloquine: Additive effect on gastrointestinal tract and atrial rate. Anticholinesterase drugs for glaucoma treatment: Additive effects. Narcotics: Exacerbation of bradycardia possible. Depolarizing neuromuscular blocking agents: Increased effect. Non-depolarizing neuromuscular blocking agents: Dose may need to be increased. Aminoglycoside antibiotics, local and some general anesthetics, anti-arrhythmic agents, and other drugs that interfere with neuromuscular transmission should be used cautiously, if at all. Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.1 Mefloquine Concomitant use of mefloquine and pyridostigmine bromide may have additive effects on the gastrointestinal tract, the most common of which is loose bowels. Additive effects on the atrial rate may also occur with concomitant use of mefloquine and pyridostigmine bromide. 7.2 Other Anticholinesterase Drugs Concomitant use of anticholinesterase drugs used in the treatment of glaucoma and pyridostigmine bromide may have an additive effect that may cause or exacerbate problems with night vision. 7.3 Narcotics The bradycardia associated with the use of narcotics may exacerbate pyridostigmine-induced bradycardia. 7.4 Drugs that Interfere with Neuromuscular Transmission Particular caution should be observed in the administration of depolarizing neuromuscular blocking agents (e.g., succinylcholine) during surgery since the degree of neuromuscular blockade that ensues may be enhanced by previously administered pyridostigmine bromide. Doses of nondepolarizing neuromuscular blocking agents (e.g., pancuronium bromide) may need to be increased in patients previously administered pyridostigmine bromide. Atropine antagonizes the muscarinic effects of pyridostigmine bromide, and this interaction is utilized to counteract the muscarinic symptoms of pyridostigmine bromide toxicity.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use extended-release tablets with intestinal or urinary blockage or allergy to anticholinesterase drugs.
  • Use caution with asthma, COPD and heart rhythm problems.
  • Kidney problems raise the risk of side effects.
  • Older adults need careful dose selection.
  • Pregnancy and breastfeeding: discuss with your doctor, as the drug passes into breast milk.
  • Safety in children is not established for military-only products.

Overdose

Too much pyridostigmine can cause cholinergic crisis, with worsening muscle weakness that can affect breathing. Extremely high doses can cause agitation, confusion and hallucinations. Treatment involves stopping the drug, supporting breathing, and giving atropine.

Half-Life and How Your Body Processes It

Pyridostigmine is poorly absorbed from the gut. It is broken down by cholinesterases and the liver, then excreted in urine. Its half-life is about 5.6 hours. Kidney problems slow its clearance, and food raises absorption of the extended-release tablet.

Storage

Store refrigerated between 2°C to 8°C (36°F to 46°F) in carton or foil overwrap to protect from light until the expiration date. Refrigerator, store at 20°C to 25°C (68°F to 77°F) in carton or foil overwrap for up to 5 years minus half of the time spent under refrigerated storage…

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Pyridostigmine

From the licensed clinical database we use, rolled up per supplement, most serious first.

39 supplements and herbal products have documented interactions with Pyridostigmine in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 28Moderate
  • 10Minor

See the other 31

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Pyridostigmine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Pyridostigmine — the kind of thing our pharmacy team would talk through with you at the counter.

What is pyridostigmine used for?

It depends on the product. Mestinon and other oral forms treat myasthenia gravis. Regonol injection reverses muscle relaxants after surgery. A military-only version is for soman nerve agent pretreatment.

Can I take pyridostigmine with food?

For myasthenia gravis products, follow your prescriber and label. The military-only extended-release tablet must be taken with a medium-fat or high-fat meal, not on an empty stomach.

What side effects should I expect?

Stomach upset such as diarrhea, cramps and nausea is most common. Muscle twitching, sweating and extra saliva can also happen. Call your doctor if they bother you.

When should I get emergency help?

Get help right away for trouble breathing, severe dizziness, fainting, or increasing muscle weakness. These can be signs of a serious reaction or too much medicine.

Does pyridostigmine interact with other medicines?

Yes. Mefloquine, narcotics, glaucoma drugs of the same type, some anesthetics, aminoglycoside antibiotics and surgical muscle relaxants can interact. Tell your pharmacist about everything you take.

Is pyridostigmine safe in pregnancy or kidney disease?

Case reports have not shown clear pregnancy risk, but animal studies showed harm, so talk to your doctor. Kidney problems raise the risk of side effects, so doses are chosen carefully.

Is pyridostigmine available over the counter?

No. Pyridostigmine is a prescription medicine: every pyridostigmine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was pyridostigmine first available?

The earliest FDA record we hold for pyridostigmine is from 1955: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when pyridostigmine was first used.

Who makes pyridostigmine?

20 companies currently list pyridostigmine products in the FDA's NDC Directory, including Bausch Health US, LLC, Amneal Pharmaceuticals of New York LLC, Method Pharmaceuticals, LLC. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of pyridostigmine?

Pyridostigmine is the generic name. Its brand names are Mestinon, Mestinon Timespan and Regonol. Generic versions are listed under the name pyridostigmine.

What is the generic name of Mestinon?

The generic name of Mestinon is pyridostigmine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is pyridostigmine?

Pyridostigmine belongs to the drug class Cholinesterase Inhibitor, its established pharmacologic class on the FDA label.

Is there a generic version of pyridostigmine?

Yes. FDA-approved generic versions of pyridostigmine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does pyridostigmine come in?

Pyridostigmine is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 30 mg and 60 mg. Oral solution (by mouth): 60 mg/5 mL. Extended-release tablet (by mouth): 105 mg and 180 mg. Injection (into a vein): 5 mg/mL. A listing does not mean every pharmacy stocks every strength.

How much does pyridostigmine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.22 to $6.94 per generic tablet across 2 strengths, $0.71 per mL of the 60 mg/5 mL generic oral solution and $3.94 per 180 mg generic extended-release tablet as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. No national price was found for pyridostigmine injections. The pharmacy prices section of this page lists every strength priced.

Is there a pyridostigmine shortage?

No. Pyridostigmine is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the pyridostigmine prescribing information (package insert)?

The full FDA-approved prescribing information for pyridostigmine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Amneal Pharmaceuticals LLC's, revised May 13, 2026, and links to it on DailyMed.

Can you crush pyridostigmine?

Some forms of pyridostigmine are on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: Mestinon Timespan (tablet, extended release); pyridostigmine bromide (tablet, extended release). An extended-release form releases the medicine over many hours, and crushing or chewing it can release the whole dose at once. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is pyridostigmine gluten free?

No pyridostigmine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 25 pyridostigmine products from 20 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's pyridostigmine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See pyridostigmine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Pyridostigmine

Skip the scrolling. Ask in your own words and get an answer from Pyridostigmine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Pyridostigmine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Pyridostigmine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Pyridostigmine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Pyridostigmine Forms and Strengths (How It Comes)

Pyridostigmine comes in 4 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Pyridostigmine inactive ingredients by manufacturer.

Tablet

By mouth
Brands Mestinon (before 1982)
How this form is used
What it may be used for
  • Mestinon tablets are used to treat myasthenia gravis.
  • A military-only pyridostigmine bromide tablet is used for soman nerve agent pretreatment.
Important instructions
  • Mestinon conventional tablets are dosed and spaced to the needs of the individual patient.
  • The military-only pyridostigmine bromide tablet is started before exposure and stopped at the first sign of nerve agent poisoning.
Available strengths 2 strengths
13 FDA-listed product records ⓘ

Oral solution

By mouth
Brands Mestinon (before 1982)
How this form is used
What it may be used for
  • Pyridostigmine bromide oral solution is used to treat myasthenia gravis.
Important instructions
  • Pyridostigmine bromide oral solution is raspberry-flavored and allows fine dose adjustment for children and “brittle” myasthenic patients.
  • Pyridostigmine bromide oral solution is easier to swallow, especially in the morning, for patients with bulbar involvement.
Available strengths 1 strength
8 FDA-listed product records ⓘ

Extended-release tablet

By mouth
Brands Mestinon (before 1982)
How this form is used
What it may be used for
  • Mestinon is used to treat myasthenia gravis.
  • Pyridostigmine bromide extended-release tablets are used to treat myasthenia gravis; a military-only product is for soman pretreatment.
Important instructions
  • Mestinon Timespan tablets release the drug slowly, which can mean fewer doses a day.
  • The military-only pyridostigmine bromide extended-release tablet must be taken with a medium-fat or high-fat meal, not on an empty stomach.
Available strengths 2 strengths
3 FDA-listed product records ⓘ

Injection

By injection · Into a vein
Brands Regonol (before 1982)
How this form is used
What it may be used for
  • Regonol is used to reverse the effects of nondepolarizing muscle relaxants.
Important instructions
  • Regonol is given by vein only, by or under the supervision of experienced clinicians.
  • Regonol contains benzyl alcohol and is not for use in neonates.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Pyridostigmine on the U.S. Market: Products, Makers and Brands

How Pyridostigmine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

20 companies list 25 Pyridostigmine product records with the FDA, mostly as tablet, oral solution, extended-release tablet; the earliest marketing or approval year on record is 1955. Brand names in the directory today include Mestinon and Regonol; the rest are generics.

4
Dose forms ⓘ
20
Labelers (makers, repackagers, distributors)
3
Brand names ⓘ
25
FDA-listed product records ⓘ
1955
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (5) · Granule (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Bausch Health US, LLC12%
Amneal Pharmaceuticals of New York LLC8%
Method Pharmaceuticals, LLC8%
Rising Pharma Holdings, Inc.8%
ANI Pharmaceuticals, Inc.4%
Acella Pharmaceuticals, LLC4%
Other makers56%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Pyridostigmine Is Used (Medicaid Data)

How many Pyridostigmine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

50,282
Medicaid prescriptions filled (Q1–Q4 2025)
$6.6M paid by Medicaid, before rebates

How commonly is Pyridostigmine prescribed? Of the 1,682 medications we measure, Pyridostigmine ranks #645 by Medicaid prescriptions — more than 62% of them.

Where Pyridostigmine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Pyridostigmine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 60 mg oral tablet is the most-dispensed Pyridostigmine product — about 85% of these Medicaid prescriptions.

pyridostigmine bromide 60 MG Oral Tablet Most dispensed

42,637 Medicaid prescriptions (Q1–Q4 2025) 85% of Pyridostigmine prescriptions shown $3.6M paid by Medicaid, before rebates ≈ $84 per prescription, before rebates

6 of 24 listed NDCs had Medicaid claims. RxNorm 903857

pyridostigmine bromide 12 MG/ML Oral Solution

3,283 Medicaid prescriptions (Q1–Q4 2025) 7% of Pyridostigmine prescriptions shown $1.2M paid by Medicaid, before rebates ≈ $362 per prescription, before rebates

5 of 11 listed NDCs had Medicaid claims. RxNorm 903843

pyridostigmine bromide 180 MG Extended Release Oral Tablet

3,099 Medicaid prescriptions (Q1–Q4 2025) 6% of Pyridostigmine prescriptions shown $1.1M paid by Medicaid, before rebates ≈ $371 per prescription, before rebates

3 of 6 listed NDCs had Medicaid claims. RxNorm 903847

pyridostigmine bromide 30 MG Oral Tablet

1,263 Medicaid prescriptions (Q1–Q4 2025) 3% of Pyridostigmine prescriptions shown $699,697 paid by Medicaid, before rebates ≈ $554 per prescription, before rebates

1 of 10 listed NDCs had Medicaid claims. RxNorm 903841

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 15 of the 51 listed Pyridostigmine NDCs had Medicaid claims.

Compare Pyridostigmine Products

A representative set of FDA-listed product records for Pyridostigmine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 25 of 25 products — FDA National Drug Code Directory. See every product, package size and price: browse all 25 Pyridostigmine NDCs →

Pyridostigmine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Pyridostigmine recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Class II Sep 30, 2022 · Terminated · VistaPharm, Inc.
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
  • Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01 Lots: Lot#: 832400, Exp 08/2023 FDA record D-0018-2023 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Pyridostigmine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
4
Strengths
6
Forms in current FDA listings
4 of 4
In current FDA listings No current FDA listing
Ingredient (IN) Pyridostigmine RxCUI 9000
  1. Dose form (SCDF) Extended Release Oral Tablet RxCUI 373707
    In current FDA listings
    Its 2 strengths (SCD)
    • 105 mg 24-hour, bromide RxCUI 2695047
    • 180 mg bromide RxCUI 903847
  2. Dose form (SCDF) Injection RxCUI 1866146
    In current FDA listings
    Its strength (SCD)
  3. Dose form (SCDF) Oral Solution RxCUI 756776
    In current FDA listings
    Its strength (SCD)
  4. Dose form (SCDF) Oral Tablet RxCUI 373706
    In current FDA listings
    Its 2 strengths (SCD)
    • 30 mg bromide RxCUI 903841
    • 60 mg bromide RxCUI 903857

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Pyridostigmine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Pyridostigmine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a form and a strength to see how its price has changed since Nov 2023.

Form
Strength

For the generic 60 mg tablet, pharmacies paid an average of $0.218 per tablet as of Nov 18, 2026, down 21% from $0.275 a year earlier.

What pharmacies pay now
$0.218
per tablet, as of Nov 18, 2026
Last 4 weeks
Down 8.2%
from $0.238 on Oct 21, 2026
Last 12 months
Down 21%
from $0.275 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.187 to $0.275
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 60 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.218
Oct 2026$0.238
Sep 2026$0.249
Aug 2026$0.265
Jul 2026$0.270
Jun 2026$0.271
May 2026$0.271
Apr 2026$0.271
Mar 2026$0.273
Feb 2026$0.269
Jan 2026$0.270
Dec 2025$0.272
Nov 2025$0.275
Oct 2025$0.265
Sep 2025$0.257
Aug 2025$0.256
Jul 2025$0.258
Jun 2025$0.269
May 2025$0.268
Apr 2025$0.266
Mar 2025$0.265
Feb 2025$0.271
Jan 2025$0.251
Dec 2024$0.244
Nov 2024$0.187
Oct 2024$0.263
Sep 2024$0.265
Aug 2024$0.267
Jul 2024$0.236
Jun 2024$0.262
May 2024$0.228
Apr 2024$0.236
Mar 2024$0.238
Feb 2024$0.197
Jan 2024$0.234
Dec 2023$0.230
Nov 2023$0.213
FormStrengthVersion What pharmacies pay
Tablet · Oral 30 mg Generic $6.94 per tablet NDC details & price history
Tablet · Oral 60 mg Generic $0.218 per tablet NDC details & price history
Extended-release tablet · Oral 180 mg Generic $3.94 per tablet NDC details & price history
Oral solution · Oral 60 mg/5 mL Generic $0.713 per mL NDC details & price history
Extended-release tablet · Oral 180 mg Generic $3.94 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Pyridostigmine Brand Names

Pyridostigmine has 3 brand names on record: Mestinon, Mestinon Timespan and Regonol. Mestinon and Regonol are in the FDA’s product directory today; Mestinon Timespan is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Mestinon before 1982 Mestinon Timespan not listed today Regonol before 1982

Who Makes Pyridostigmine: Manufacturers and Labelers

20 companies list Pyridostigmine products with the FDA. By number of product records, the largest are Bausch Health US, LLC, Amneal Pharmaceuticals of New York LLC, Method Pharmaceuticals, LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bausch Health US, LLC 3 Amneal Pharmaceuticals of New York LLC 2 Method Pharmaceuticals, LLC 2 Rising Pharma Holdings, Inc. 2 ANI Pharmaceuticals, Inc. 1 Acella Pharmaceuticals, LLC 1 Alvogen, Inc. 1 American Health Packaging 1 Amneal Pharmaceuticals LLC 1 Amneal Pharmaceuticals NY LLC 1 Apnar Pharma LP 1 Golden State Medical Supply, Inc. 1 Major Pharmaceuticals 1 Novadoz Pharmaceuticals LLC 1 Novitium Pharma LLC 1 Sandoz Inc 1 Surgeon General-Department of the Army (TSG-DA) 1 VistaPharm, LLC 1 Zydus Lifesciences Limited 1 Zydus Pharmaceuticals (USA) Inc. 1

Sources for This Pyridostigmine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated May 13, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Pyridostigmine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 27 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
27
Finished products in the current FDA directory
25
Companies listing them (makers, repackagers, distributors)
20
FDA labeler codes behind them ⓘ
21
Linked representative label ⓘ
Amneal Pharmaceuticals LLC
Linked label effective
May 13, 2026
Composite sections available
25
Linked SPL Set ID
52d6f195-165a-400b-a13b-489e94bcf0b0
Linked SPL Document ID
d6813c89-ca7b-4495-86ac-137a38854371
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amneal Pharmaceuticals LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →